Back to search

Article

Structural basis for the unexpected activity of rifamycin B against rifampicin-resistant RNA polymerase

2026-07-14

Abstract excerpt

<h4>Summary</h4> Rifamycins inhibit bacterial transcription by targeting RNA polymerase (RNAP), but their clinical effectiveness is limited by the rapid emergence of resistance caused by mutations within the rifamycin-binding pocket. Rifamycin B (Rif B), one of the earliest discovered members of this antibiotic family and a precursor of clinically used derivatives, has remained poorly characterized because of its...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0de4d5f7-6285-5696-a552-2c52f57e874f
DOI
10.64898/2026.07.13.738162
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Structural basis for the unexpected activity of rifamycin B against rifampicin-resistant RNA polymeraseDOI 10.64898/2026.07.13.738162
Select a neighboring publication to make it the new centre.